Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ABBOTT LABORATORIES Stock Hits Price Target with 9.59% Profit

January 23, 2025
QuantWave, a leading automated forecasting platform, has successfully predicted a price target for ABBOTT LABORATORIES stock, resulting in a 9.59% profit for investors. The forecast signal was issued on October 1, 2024, when the price stood at 111.42 $. The direction indicated was long, and on January 23, 2025, the stock reached the target price of 122.1 $.

This achievement showcases the accuracy and reliability of QuantWave's analytics in predicting stock movements. The successful forecast for ABBOTT LABORATORIES highlights the platform's ability to provide users with valuable insights for making informed investment decisions.

Several factors likely contributed to the stock's movement, including strong financial performance, favorable market conditions, and positive developments within the healthcare industry. ABBOTT LABORATORIES' innovative product portfolio and strategic initiatives may have also played a role in driving the stock price higher.

QuantWave offers users the opportunity to access predictions for a wide range of stocks, presenting potential opportunities for profits. For investors interested in delving deeper into the platform's investment strategy, QuantSchool provides a comprehensive professional framework for generating consistent income using QuantWave's forecasting system.

Overall, the successful prediction for ABBOTT LABORATORIES stock underscores QuantWave's proficiency in delivering accurate and actionable insights for investors seeking to optimize their investment strategies.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTFebruary 28, 2024ABBOTT LABORATORIES Stock Hits Forecasted Price Target with 13.42% Profit  ~2 min.

On July 18, 2023, QuantWave's forecast signal predicted a long position for ABBOTT LABORATORIES stock when it was trading at $102.80....


ABTOctober 12, 2023ABBOTT LABORATORIES Hits Forecast Price Target with 10.91% Profit, Confirming QuantWave's Accuracy  ~2 min.

Abbott Laboratories (NYSE: ABT) recently achieved the forecast price target set by QuantWave, signaling a profitable short position for investors....


ABTJanuary 23, 2025QuantWave Achieves 20.32% Profit Target Forecast for ABBOTT LABORATORIES  ~1 min.

QuantWave, the automated forecasting platform, successfully reached its price target prediction for ABBOTT LABORATORIES, signaling a profitable long position....


ABTFebruary 5, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 14.01% Profit: QuantWave Analysis  ~1 min.

Abbott Laboratories' stock recently achieved the price target forecast set by QuantWave, resulting in a profit of 14.01% for investors. The forecast signal date was November 12, 2024, with a price of 114.78$....


ABTFebruary 20, 2025ABBOTT LABORATORIES Achieves Price Target Forecast with 15.9% Profit  ~1 min.

QuantWave's forecast for ABBOTT LABORATORIES reached its target on February 20, 2025, generating a profit of 15.9%. The forecast signal date was December 10th, 2024, with a price of $114....